ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_8051_4 # 3931 # 4326 # -1 # ID=7_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.412	k141_8051_4 	3931	4326	-	Strict	700	22.3274	ADC-19	100.0	3003863	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGATAGTAACTACCGACATAGGAAACATTCTCTATCGGGACTGCAAGGCTTTCGGAATAGATATAGTGCCTGATGGTGAAACGCTGACGGGTGAATTGAAGTCCGAAAGGATTGTCATCCACACGAAGAAACAACAGCCGGGAAAGTATTGGAAGAAATCTTTTGCAGAAGTGAATCTATGTGTACCCAATTTAAGCGAGAATGAAGCGAACACAATCCGGCTTAACGAACTTGAAAGAAAGGCTGACAAGCTGCTTGATGATGTAGTAAGCACCTATGACGGTACAACCTATCGTTACTCTATCGAATCAATTGGCGCGGAAGCGGATGCAGCTTTGAAATGCCATTACGTGAATGTGAGAATTTTATTTGAAGTAATAAATGTAAAACTATAA	MIVTTDIGNILYRDCKAFGIDIVPDGETLTGELKSERIVIHTKKQQPGKYWKKSFAEVNLCVPNLSENEANTIRLNELERKADKLLDDVVSTYDGTTYRYSIESIGAEADAALKCHYVNVRILFEVINVKL	MRFKKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKLKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	34.20	gnl|BL_ORD_ID|2423|hsp_num:0	2349	True	loose hit with at least 95 percent identity pushed strict
k141_55890_1 # 3 # 938 # -1 # ID=12_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.407	k141_55890_1 	3	938	-	Strict	1200	629.787	tetQ	96.79	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATTTCTTCTTTTATACTTCCTCCGGCATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGGCATAAAAGAAGTTTTCTTAAAATAATTGACGGAAGTCTGAGACTTCGAGACGTTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGTGCCAATGATATCGCGATTGTAGAAGATATAGAAGATTTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGATTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAAATAAGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGGTTTTCCGTCAAGATCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACAGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGAC	MFNIGINELLDAISSFILPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKIHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVD	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	47.49	gnl|BL_ORD_ID|1116|hsp_num:0	1183	True	loose hit with at least 95 percent identity pushed strict
k141_819_2 # 1700 # 2665 # -1 # ID=37_2;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.357	k141_819_2	1700	2665	-	Perfect	600	661.374	CfxA3	100.0	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTGATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|1790|hsp_num:0	1895		
k141_24682_57 # 63990 # 67091 # -1 # ID=45_57;partial=00;start_type=ATG;rbs_motif=AAAAA;rbs_spacer=12bp;gc_cont=0.452	k141_24682_57	63990	67091	-	Strict	750	770.385	adeF	41.86	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTTAGTTTCTTTATAGACAGACCGGTATTTTCAGCTGTCATCTCCATATTAATAGTCATTGTCGGTATCATCGGTCTCACGATGCTACCCATTGACCAATATCCGCAGATTACCCCGCCGGTAGTGAAAATCAGCGCATCCTATCCGGGTGCCAGTGCCCTGACAGTATCACAAGCAGTAGCCACTCCTATAGAACAGGAATTGAACGGTACTCCAGGAATGCTTTACATGGAATCAAACAGTTCCAATTCGGGAGGTTTTTCAGCCACCGTCACTTTTGATATCTCGGCAGATCCCGATCTGGCGGCAGTAGAAATACAGAACCGTATCAAGTTAGCAGAATCACGTCTTCCAGCAGAAGTTATACAAAATGGTATTTCGGTAGAGAAACAGGCTGCCAGTCAATTGCTAACCCTATGCCTTACCTCTACCGACCCGAAATTCGATGAAATATACCTTAGCAACTTTGCTACTCTGAATGTACTGGACCTAATCCGCCGTATCCCTGGCGTAGGACGTGTTTCAAACATCGGAAGCCGATATTACGCCATGCAAATTTGGGTACAGCCCGACAAACTGGCCAATTTCGGTCTGACCGTAGCCGATCTGCAGAATGCACTGAAAGACCAAAATCGGGAATCAGCAGCCGGTGTACTGGGACAACAACCCGTACAAGGATTAGACGTAACCATTCCCATCACTACTCAGGGACGTCTATCTACTGTAAGCCAGTTTGAGGAAATCGTAGTCCGTGCCAATGCCGATGGTTCCATCATCCGTTTACGTGATGTGGCCCGCATCTCACTCGAAGCACAATCATACAATACCGAGAGTGCCATTAACAAAGAAAATGCAGCGGTATTGGCCATCTATATGTTACCGGGAGCCAACGCTATGGAAGTAGCAAAAAGCGTGAAAGAAGCTATGGAGGAAATCAGCAAGAATTTCCCCGAAGGAATGAGTTACGAGATACCTTTCGATATGACCACATATATTTCGGAATCTATTCATGAAGTGTACAAAACACTGTTTGAAGCCCTGATACTGGTTATTATCGTAGTATACCTTTCACTCCAAAGCTGGCGTGCAACAGTTATCCCACTAGTTGCCGTACCTATCTCACTGATTGGAACTTTCGGATTCATGTTGATTTTCGGATTCTCGCTTAATATCCTGACCCTGTTGGGGTTGGTACTTGCCATCGGTATTGTGGTGGACGATGCTATCGTGGTAGTAGAGAATGTGGAGCGTATCATGGAAGAGGAGAAACTATCTCCCTACCAAGCTACCAAGAAAGCTATGGAAGGACTTACAGGAGCCATTATCGCCACTTCTTTGGTACTGGCAGCAGTATTTGTTCCCGTAAGTTTTCTAGGTGGAATTACCGGACAACTTTATCGCCAGTTTACGGTAACCATCGTAGTATCCGTATTGCTGTCTACGGTAGTAGCTTTGACATTGAGTCCAGTCATGTGTTCGCTTATCCTGAAACCGGAAGATCCGAACAAGAAAAAGAATATCGTATTCCGCCGTATCAATGAGTGGCTGGCTATCGGCAATCATAAATATGTAGGGCTTATCAAACACATTGTGAAACACCCGCGTCGGGTACTGAGCACATTCGGCATGGTATTGATCGCCATCCTGTTAATCCATCGCATTATTCCCACCAGCTTCCTCCCCATCGAAGACCAAGGGTATTTTAAAATAGAGTTGGAGCTACCCGAAGGTGCAACGTTGGAACGTACACGTATCGTAACAGAACGTGCTGTGGAATACCTGATGAAAAATCCGGCAGTGGAATATGTGCAAAGCGTGGCGGGAAGCAGTCCGCGTGTAGGAACCAGTCAGGCACGAAGTGAACTGACTGTCATCTTAAAACCTTGGGAGGAACGTGACTCGCAAACTATTGACAATATTATGGCACAGGTAAAAAAAGACATGTCACAATACCCCGAATGCAAGGTATATCTTTCCACCCCTCCCGTTATTCCGGGATTGGGCAGTTCGGGCGGGTTCGAAATGCAATTGGAAGCACGTGGAGATGCCACTTTCGAAAATTTGGTACAAGCTACGGATACATTGATGTATTATGCATCAAAACGTAAGGAATTATCAGGTTTATCTTCGGCTTTACAAGCGGATATCCCCCAACTTTATTTTGATGTAGACCGTGACAAAGTAAAATTCTCAGGAGTACCTTTAGCCGATGTATTCTCGACTATGAAAGCTTATACAGGTTCGGTATATGTAAACGATTTCAATATGTTTAACCGCATCTACCGTGTATATATTCAAGCAGAAGCACCCTACCGGGAACATAAGGAGAATATCAACCTGTTTTTTGTACGGGGTACAGACAATGCCATGATACCGCTCACCTCGCTGGGTACCACTTCGTATACCACTGGTCCGGGCAGCATCAAACGTTTTAATATGTTCAACAGTTCTGTGATTCTCGGTGAGGCCGCAGACGGTTACAGTTCAGGACAGGCTATGGAAATTATCGAACAAATAGCCCGCGAACACCTACCGGAAAATATCGGTGTAGAATGGAGCGGACTATCCTTCCAGGAAAAACAGGCAGGTGGACAGACCGGCATGGTGCTGGCATTAGTGTTCATGTTCGTATTTTTGTTCCTTGCTGCCTTATACGAAAGCTGGATGGTACCGGTTGCAGTATTACTCTCTTTGCCTGTAGCCGCATTAGGTGCTTATCTAGGTGTATGGGGCTGTGGACTGGAGAATGATGTCTATTTCCAGATCGGATTGGTGATGTTGGTAGGACTAGCCGCCAAAAATGCAATTCTTATTGTAGAGTTTGCCAAAGAACAAGTAGACAAAGGAGTAGATGTAGTACAAGCTGCACTTCATGCTTCACAGCTCCGTTTCCGACCTATTTTGATGACTTCATTGGCATTCATCTTAGGTATGTTACCTATGGTCATTGCCAGCGGGCCAGGTTCAGCCAGCCGTCAGGCTATTGGTACAGGTGTATTCTTCGGAATGATCTTTGCTGTAACTGTGGGAATTTTGTTAGTACCTTTCTTCTTTGTACTGATATACAAGATGAAAGCGAAGATGAAACAAAAATAA	MKVSFFIDRPVFSAVISILIVIVGIIGLTMLPIDQYPQITPPVVKISASYPGASALTVSQAVATPIEQELNGTPGMLYMESNSSNSGGFSATVTFDISADPDLAAVEIQNRIKLAESRLPAEVIQNGISVEKQAASQLLTLCLTSTDPKFDEIYLSNFATLNVLDLIRRIPGVGRVSNIGSRYYAMQIWVQPDKLANFGLTVADLQNALKDQNRESAAGVLGQQPVQGLDVTIPITTQGRLSTVSQFEEIVVRANADGSIIRLRDVARISLEAQSYNTESAINKENAAVLAIYMLPGANAMEVAKSVKEAMEEISKNFPEGMSYEIPFDMTTYISESIHEVYKTLFEALILVIIVVYLSLQSWRATVIPLVAVPISLIGTFGFMLIFGFSLNILTLLGLVLAIGIVVDDAIVVVENVERIMEEEKLSPYQATKKAMEGLTGAIIATSLVLAAVFVPVSFLGGITGQLYRQFTVTIVVSVLLSTVVALTLSPVMCSLILKPEDPNKKKNIVFRRINEWLAIGNHKYVGLIKHIVKHPRRVLSTFGMVLIAILLIHRIIPTSFLPIEDQGYFKIELELPEGATLERTRIVTERAVEYLMKNPAVEYVQSVAGSSPRVGTSQARSELTVILKPWEERDSQTIDNIMAQVKKDMSQYPECKVYLSTPPVIPGLGSSGGFEMQLEARGDATFENLVQATDTLMYYASKRKELSGLSSALQADIPQLYFDVDRDKVKFSGVPLADVFSTMKAYTGSVYVNDFNMFNRIYRVYIQAEAPYREHKENINLFFVRGTDNAMIPLTSLGTTSYTTGPGSIKRFNMFNSSVILGEAADGYSSGQAMEIIEQIAREHLPENIGVEWSGLSFQEKQAGGQTGMVLALVFMFVFLFLAALYESWMVPVAVLLSLPVAALGAYLGVWGCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKEQVDKGVDVVQAALHASQLRFRPILMTSLAFILGMLPMVIASGPGSASRQAIGTGVFFGMIFAVTVGILLVPFFFVLIYKMKAKMKQK	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.54	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_21854_6 # 4825 # 7941 # 1 # ID=90_6;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=3bp;gc_cont=0.494	k141_21854_6	4825	7941	+	Strict	750	788.104	adeF	43.25	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTTCAAAATTCTTCATAGAACGGCCTATATTTGCCACAGTACTGGCTTTGTTATTTGTGGTGGCCGGACTTGTTACATTAAATATATTGCCCGTGGCGCAATATCCCGATATTACGCCGCCTACCGTGCAAGTCAGTGCGGTATATCCGGGAGCTAATGCTGAAACGGTCGCACAGACCGTAGGTATCCCCATTGAACAGCAGGTGAACGGTGTGGATGGAATGTTGTATATGAGCTCCAATTCTTCCGCATCGGGTGCTTATTCGCTGACCGTGACTTTCGAAGTGGGAACGGATGTCGATATGGCTACCGTAATGGTGCAAAACCGTGTCAGTGTGGCATTGAATTCCCTGCCCGAAGCGGTGAAAGTGCAAGGAGTAACGGTGCAGAAGCAGTCATCCAATATTGTGATGATGCTTACACTGAGCGGTGACAGTATTTATGATGGCCTCTATCTGACCAATTATGCCAATTTGAATCTGGTAGACCAGTTGACCCGTGTACCGGGAGTGGGAGCGGTGAATGTCATGGGAGCCGGTGATTACTCCATGCGTGTATGGTTGAATCCCGAAACCATGCGTATCCGCAATATTACTCCGCAGCAGGTTTACTCTGCCATTCAAAGTCAGAATATGGAAGTGTCTGCCGGTTATGTGGGACAGCCCATCGGCAGTTCGGCCGATAATGATTTTCAATATACGCTGAATGTAAAGGGACGTCTCTCTACTCCCGAAGAGTTCGGCGACATCATATTGAGAGTGGAAGACCAGGGGAAAGTGCTCCGTCTGAGGGACGTTGGCAGAATCGAGCTGGGTAGTGCCGAGTACGGAGTTGTTTCCAGGTTGAAAGGACAACCTACGGCTGCTATCGCCGTCTATCAGCTGCCGGGAAGTAATTCGCTGGATGTATCCAAGGGAGTTCGTGCGCGCATGGCGGAACTGGCCGAGACATTTCCGGCCGGGGTGAAGTACAATGTGACGTTGGATACCACAGATGTGGTGCATGACTCCATTGACGAAGTGATGAAGACTTTCGTGGAAGCGATTATCCTGGTGGTGCTGGTTATCTTTTTCTTCCTGCAAAGCTGGCGGGCGGTTCTTATCCCATGCCTCACTATCCCTGTATCCCTTATCGGAACATTGGCAGTAATGGCTGCCTTGGGCTTCTCTATCAATACGCTGACTCTGTTCGGGTTGATCCTGGCTATTGCCATTGTGGTGGATGATGCCATTGTGGTGACCGAGAATGCTACCCGTATTCTGGACGAAGGGAAACTGGATGCTCGTGCCGCTACCGAGCAGGCGATGGGGGAGATTACCGGGCCTATTGTCGGAGTGGTGCTGGTACTGCTTGCCGTATTTATTCCTACTACGCTGATTAGCGGTATTTCCGGGCAGCTTTATAAGCAGTTTGCTTTGACCATCGCGGCTTCTACGGTGATAAGCGGTTTCAATTCACTGACATTGACGCCGGCAGTCTGTGCCTTGTTGTTACGTCCCACTCCGGCTCATAAAGCACGCTTGTTCCGGTGGTTTGACAGTATGAATGACTGGATGCAGCGGGTTTATGACGCTTCGGTGAAATGGTTGTTGGCACGGCCGGTCATTGCCATCGGCTCTTATGTGGTTATATCAATCATTGCCATTCTGATGTTTGTGAAATGGCCGAGTACCTTTATACCCGAAGAAGATGACGGATACTTTATGATTGCCATTCAGCTTCCGGCTGCTTCTTCTTTGGAACGTACGCAGAGGGTGGGTAAACAGATTGATGCTATTTTGGCAGAGTATCCCGAAGTGAAGACTTATTTGGGCGTAAACGGGTTCAGTATCATGGGAGGAGGGCAGTTGCCTAACGCGGCTACTTATTTTGTGGTGCTGAAAAATTGGAAGGAACGTGCGGGCAAGGAGCATACGGCCCAGGCAGTGGTCAATCGTTTTAACGGACAGGCTTATGCCATGATTCAGGAGGCTCAGGTTTTTGGTATTATTCCTCCGGCTATTCCGGGTATGGGTAATACAGGCGGCTTGCAGCTTGAACTGGAAGACCGTAAGTCTTTGGGTGCCGAGGAACTGCAAAAGGCGGTTGAGGCTTTGCTGGTCAATTATCACACTGAACCGGCCATTGCTTCCATGAGTAGTATGTATCAGGCAGATGTCCCTCAGTATTTTCTGAATATAGACCGTGACAAAGTTCAGTTGATGGGCTTACAGTTGAACCAGGTGTTCTCTACATTGGGGTATTACATGGGACAGGCTTATGTCAACGACTTTGTGGAATTTGGCCGTATTTATCAAGTGAAACTGGAAGCCGGTGAGCAGGCACAGAAGGTGATAGATGATGTGCTGAAACTGAGTGTGGCCAATTCAAAGGGAGAGATGGTTCCCTTCAGCAGTTTTACGCAGATAGAGCAGAAGCTGGGTATGGACCAGATAAACCGGTATAATATGTATTCGGCCGCTTCCATCACTATCACTCCGGCTGCCGGAAGCAGTTCCGGACAGGCGATAGAGGCTGTGGGGAGCTTGATAAAAAATCAATTGGGCAATGAGTTTGGTTATGAATGGACTTCAGTTGCTTATCAGGAAACTCATTCCGGTAATACCACTACCATTATTCTGATTATGGCGTTGCTGGTGGCATATCTGGTGTTGGCGGCACAGTATGAAAGCTGGACAAGTCCGGTCGCTGCTGTGATGGGCTTGCCCGTAGCTATTCTGGGTGCGATGCTCGGTTGCTGGGTGATGGGAGTTCCGGTCAGTATCTATACGCAGATCGGTATTATTCTGCTGATTGCTTTGTCTGCGAAGAATGGTATTTTGATTGTGGAATTTGCCCGTGATTACCGTAAAGCCGGCAATCCTATCCGTGAGGCGGCATACGAGGCAGGGCATGTGCGCTTGCGTCCTATCCTGATGACCTCATTTACCTTCGTGCTGGGTGTGATGCCGTTGTTGTTTGCCACAGGCGCCGGTGCCGGTAGCCGTGTGGCGCTGGGTGCGGCAGTGGTATTCGGTATGGCAGTGAATACGATTTTTGCTACCATTTATATTCCTAACTGGTATGAAGTGATGCAGAATATTCAGGAGAAATGGTTGACTAAGAAAAAATAA	MFSKFFIERPIFATVLALLFVVAGLVTLNILPVAQYPDITPPTVQVSAVYPGANAETVAQTVGIPIEQQVNGVDGMLYMSSNSSASGAYSLTVTFEVGTDVDMATVMVQNRVSVALNSLPEAVKVQGVTVQKQSSNIVMMLTLSGDSIYDGLYLTNYANLNLVDQLTRVPGVGAVNVMGAGDYSMRVWLNPETMRIRNITPQQVYSAIQSQNMEVSAGYVGQPIGSSADNDFQYTLNVKGRLSTPEEFGDIILRVEDQGKVLRLRDVGRIELGSAEYGVVSRLKGQPTAAIAVYQLPGSNSLDVSKGVRARMAELAETFPAGVKYNVTLDTTDVVHDSIDEVMKTFVEAIILVVLVIFFFLQSWRAVLIPCLTIPVSLIGTLAVMAALGFSINTLTLFGLILAIAIVVDDAIVVTENATRILDEGKLDARAATEQAMGEITGPIVGVVLVLLAVFIPTTLISGISGQLYKQFALTIAASTVISGFNSLTLTPAVCALLLRPTPAHKARLFRWFDSMNDWMQRVYDASVKWLLARPVIAIGSYVVISIIAILMFVKWPSTFIPEEDDGYFMIAIQLPAASSLERTQRVGKQIDAILAEYPEVKTYLGVNGFSIMGGGQLPNAATYFVVLKNWKERAGKEHTAQAVVNRFNGQAYAMIQEAQVFGIIPPAIPGMGNTGGLQLELEDRKSLGAEELQKAVEALLVNYHTEPAIASMSSMYQADVPQYFLNIDRDKVQLMGLQLNQVFSTLGYYMGQAYVNDFVEFGRIYQVKLEAGEQAQKVIDDVLKLSVANSKGEMVPFSSFTQIEQKLGMDQINRYNMYSAASITITPAAGSSSGQAIEAVGSLIKNQLGNEFGYEWTSVAYQETHSGNTTTIILIMALLVAYLVLAAQYESWTSPVAAVMGLPVAILGAMLGCWVMGVPVSIYTQIGIILLIALSAKNGILIVEFARDYRKAGNPIREAAYEAGHVRLRPILMTSFTFVLGVMPLLFATGAGAGSRVALGAAVVFGMAVNTIFATIYIPNWYEVMQNIQEKWLTKKK	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.02	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_70725_1 # 2 # 139 # -1 # ID=115_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.348	k141_70725_1 	2	139	-	Strict	500	95.9005	ErmF	100.0	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTT	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGF	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	17.29	gnl|BL_ORD_ID|582|hsp_num:0	621	True	loose hit with at least 95 percent identity pushed strict
k141_70725_49 # 35819 # 36985 # 1 # ID=115_49;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.374	k141_70725_49	35819	36985	+	Strict	750	799.66	tetX	99.74	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	100.00	gnl|BL_ORD_ID|732|hsp_num:0	776		
k141_35337_2 # 644 # 1849 # 1 # ID=126_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.414	k141_35337_2	644	1849	+	Strict	700	792.727	Mef(En2)	99.5	3004659	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATCATTGGAAATCAACTTTGGCCGTGATAGGAATAGGCCAACTCATATCTATTTTAACAAGTACGATTGTTGGCTTCTCCATTATTTTTTGGATTAGCAACGAATTTAAATCCCCGACAGCTTTATCTCTGGCTATTTTAGCTGGATTTTTACCACAATTTGTATTAGGCTTGTTTGCCGGGGTCTATGTTGACAGATGGAATCGAAAGAAAACGATGTTTTATTCGGACTTGTTCATCGCGTTCTGTACCCTATGTCTTTTTATTGTGATAACCAAGGGTTATAAAGACCTTTCTTTTTTTTATCTATTGACTGCTTGTCGTTCAATAGGCAGTACGTTTCATGCACCTGCTTTACAGGCAAGCATCCCTCTACTGGTTCCCAAGCACCATCTTGTCAGGGTATCAGGTTTGTACCATTCCATTCAATCCTTCAGTGAGGTGATAGCCCCCGTTGTAGGGGCAAGCCTCGTTGTTTGGCTTCCCATACAGTATATTCTGCTCATAGATGTGATCGGAGCTGTTGCTGCTTGTCTGACCTTACTTTGTGTCCAGATTCCTTCTCTTCAAAAAACGAAAGTTCTTCCAGATTTCAAAAAAGAACTGACGGAATGTTGGCATACCTTGCGGCGTACAATGGGCATTTTGCCTTTATTCGTATGCTTTACGCTGGTGACTTTTGTCCTTATGCCTGTTTTTACGTTATTTCCTTTTATGACGCTTCTGCATTTCAACGGAAACATTTTGCAAATGGGAGTTGTGGAAATGGGTTGGGGCTCAGGGGCATTGTTGGGCGGTTTAGTACTTGCCTGTAAGGCTTTGAAAAGCAAGCAAACATTAGTGATGCATACGGCTTATGTGATATTGGGATTGTATCTGATTAGCGCCAGTTATTTACCATCAAGCGCATTTATAGGTTTTGTTTGCCTAACATTTACAGGAGGCATAGCCTATTCCATTTACCATGCGCTTTTCATCGCTATTATTCAGCAGAACTTGGCTTCGGACATGCTTGGACGGACTTTTTCTCTCATCTTTAGTTTGAGTACCTTTCCATCAATGCTGGGTATCGTAGCTTCAGGATATTGGGTGGAAGCATGGGGTATCACATCCGTCTTTATGATCAGCGGATGGGTTATCTTTCTGATTGGAGTGGGTGCAAATTTTATTTCTTCAATCAAGCAGTTGGATAATTACGCATAG	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTECWHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	100.00	gnl|BL_ORD_ID|2256|hsp_num:0	3359		
